Tirzepatide reduces cardiac microvascular injury in diabetic mice, study finds

The wire

1. 01In European Journal of Pharmacology, male C57BL/6J mice on high-fat diet plus streptozotocin given tirzepatide for eight weeks showed less ventricular dilation, fibrosis and microvascular injury, with lower 4-hydroxynonenal, malondialdehyde and ferrous iron.
2. 02Adds a ferroptosis and mitochondrial quality-control mechanism to the cardiovascular story clinicians hear around incretin therapy.
3. 03Authors state receptor dependence, mitophagic flux and independence from systemic metabolic improvement remain unresolved; findings are from mice and cultured human endothelial cells.

From the source

Tirzepatide attenuates cardiac microvascular injury and ferroptosis-related lipid peroxidation in diabetic mice: endothelial responses in the context of partial PRKN silencing

European journal of pharmacology · 2026 Oct 2 · Lu G, Wang X, Zhuang H et al.